YAZ Side Effects Lawsuit News Archive

Pfizer recall the newest troubling development around birth control
- Washington Post
02/01/2012 - A little more than 50 years after oral contraceptives were born, women may not be able to rely on that trusty little pill any more. Pfizer Inc. announced Wednesday that it is recalling 1 million packets of birth control pills. The company says a packaging error means many women could have gotten an inadequate dose of the drug if they took Lo/Ovral-28 or generic norgestrel/ethinyl estradiol pills. Some women could have gotten pregnant accidentally.
READ MORE::

FDA connections should not affect women’s health
- The Guilfordian
01/30/2012 - While we have a responsibility for our health, I’m left wondering if possible corruption within the drug industry often prevents us from being well enough informed to begin to carry out this responsibility.
READ MORE::

Are Your Birth Control Pills Safe?
Yaz and Yasmin pills are under scrutiny after thousands of complaints.
- Shape
01/24/2012 - Last year during my annual exam, when I complained to my doctor about my terrible PMS, she was quick to pull out her pad and give me a prescription for the birth control pill Yaz. "You're going to love this," she said. "All of my patients that are on it think it's the best. It's even helped some of them lose weight!"
READ MORE::

Stanford doctor in birth control vote had ties to pill's maker
- California Watch
01/21/2012 - A watchdog group is calling on the Food and Drug Administration to throw out a joint committee's vote in support of a controversial oral contraceptive because four members of the committee – including a Stanford University professor of obstetrics and gynecology – had ties to the maker of the birth control pill that were not disclosed to the public during the meeting.
READ MORE::

Ennis & Ennis, P.A. Questions Why the FDA Allowed Five Members to Sit on Yaz Birth Control Advisory Panel Despite Conflicts of Interest
- Ennis & Ennis
01/17/2012 - In December 2011, a U.S. Food and Drug Administration (FDA) advisory panel voted 15-11 that the benefits of drospirenone-containing birth control pills, such as Yaz and Yasmin, outweigh the risks. Interestingly, though, an investigation by the Washington Monthly and the British Medical Journal (BMJ) found that at least four members of the committee have either done work for the drugs’ manufacturers or licensees or received research funding from them. The FDA made none of those financial ties public.
READ MORE::

FDA Yaz Panel Had Ties to Industry
- MedPage
01/14/2012 - Several members of the FDA advisory committee that endorsed drospirenone-containing birth control pills had ties to Bayer, the company that makes the two most popular drospirenone-containing drugs, Yaz and Yasmin, according to a media report.
READ MORE::

Group seeks re-vote on birth control clot risk
- Reuters
01/13/2012 - A watchdog group on Thursday urged the Food and Drug Administration to hold a new vote about blood clot risks from popular birth control pills, after advisers to the agency were shown to have ties to the pillmakers. The FDA asked outside experts in December to discuss the safety of birth control that contains the compound drospirenone, including Bayer's Yaz and Yasmin.
READ MORE::

Herndon will hold Yaz and Yasmin bellwether trials if mediation fails
- The Madison Record
01/12/2012 - U.S. District Judge David Herndon, who canceled a Jan. 9 trial over Bayer contraceptives and ordered mediation instead, followed up by ruling that trial will start on April 30, if mediation in good faith fails. In a Jan. 10 clarification of a Dec. 31 order, he warned that if Bayer and plaintiffs don't act in good faith, he'll start remanding cases to districts where they began.
READ MORE::

A Conflicted FDA Panel, Bayer & Birth Control Pills
- Pharmalot
01/11/2012 - Last month, an FDA advisory committee voted 15-to-11 that the benefits of the Yaz and Yasmin birth control pills outweigh the risks, and so the drugs should remain on the market, albeit with added information about the risk of blood clots. The decision followed a long-running controversy - studies by Bayer, which sells the pills, found there is no risk, while other studies say the risk is evident.
READ MORE::

Yaz Birth Control Case Ordered to Mediation
- Ennis & Ennis
01/06/2012 - The first Yaz pulmonary embolism lawsuit that was scheduled to begin trial January 9, 2012 will not begin as planned. The Honorable David Herndon, who is the presiding judge on many Bayer birth control pill lawsuits, ordered the case to mediation. “This is a good sign for both parties to begin the process of a global resolution to the litigation,” commented attorney Holly Ennis of Ennis & Ennis, P.A.
READ MORE::

Judge calls off Yaz trial, orders suits into mediation
- FiercePharma
01/04/2012 - The first Yaz trial won't open as scheduled. A federal judge delayed the bellwether patient lawsuit, set for trial next week, and appointed a special master to mediate instead. And this special master is well versed in pharma liability litigation: It's George Washington law professor Stephen Saltzburg, who handled mediation in 26,000 Seroquel lawsuits.
READ MORE::

Yaz - Yasmin Birth Control Lawsuit Test Trials Scheduled to Begin Next Year
- Ennis & Ennis
01/02/2012 - Bayer is facing more than 7000 lawsuits over its popular birth control pills Yaz and Yasmin over serious side effects such as blood clots, deep vein thrombosis (DVT), gallbladder disease, and other cardiovascular complications. Many of the lawsuits allege that Bayer failed to adequately warn about these risks.
READ MORE::

Use of birth control pills leads to clogged veins
- CNN-IBN
12/19/2011 - New Delhi: A study has revealed that usage of birth control pills puts one at a greater risk for developing clogged veins and arteries. Shalini with more on that. Popular birth control pills, Yaz and Yasmin, may leave one at a higher risk of clogged veins and arteries. In the US, the FDA has asked for new warning labels, which is something pharma major Bayer has said it will do.
READ MORE::

FDA advisory panel recommends stronger warning for drospirenone-containing birth control
- Modern Medicine
12/16/2011 - An FDA advisory panel has recommended that some oral contraceptives may need stronger warning labels, according to recent reports. The day-long joint meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of FDA was to involve discussion on the risks and benefits of drospirenone-containing birth control pills because of emerging safety concerns over the potentially higher risk of venous thromboembolism associated with these drugs compared with levonorgestrel-containing drugs, according to FDA meeting materials.
READ MORE::

FDA panel urges warnings for Yaz, Yasmin; now what?
- Consumer Reports
12/16/2011 - Well-known birth control pills such as Yaz and Yasmin need stronger warnings about the risk of blood clots, an FDA advisory committee reportedly recommended last week. This comes on the heels of the agency’s recently released analysis showing the drugs pose a greater risk of clots compared to older birth control pills. The FDA acknowledged that other studies have not found such an increase. With all the controversy, where does this leave women who take Yaz and related oral contraceptives?
READ MORE::

FDA Panel Protects Yaz Profits Over Women’s Safety
- Ennis & Ennis
12/13/2011 - The US Food and Drug Administration (FDA) advisory committee voted 21-5 on Thursday that labeling on Bayer's popular Yaz and similar birth control pills is inadequate and should be revised to better reflect the higher risk of blood clots associated with these drugs, compared with older oral contraceptives. Ennis & Ennis, P.A. explains the panelists want the label to make clearer the potential risk of blood clots in the legs and lungs from taking the pills, and that clots can be fatal. Currently the label only informs women about the conflicting studies on the blood clot risks.
READ MORE::

Users of Yaz could soon see a new warning about blood clot risks
- The Boston Globe
12/12/2011 - The newer generation birth control pills, which include Yaz, Yasmin, and Beyaz, may soon be slapped with a new warning label that says the products are more likely to cause blood clots than other forms of oral contraceptives. That’s after an expert panel convened yesterday by the US Food and Drug Administration concluded -- in a 21 to 5 vote -- that the labels currently on these products didn’t adequately reflect the risk of developing blood clots in the legs that could turn life-threatening if they wind up in the lungs.
READ MORE::

Does Yaz birth control cause deadly blood clots?
- The Week
12/12/2011 - One of the most widely used oral contraceptives in the U.S. may be getting a new warning label — a label that would describe the risks of potentially fatal blood clots. Here's what you should know:
READ MORE::

Yaz Birth Control Needs More Risk Information, FDA Says
- Huffington Post
12/09/2011 - The Huffington Post reports that Federal health experts said Thursday that drug labeling for Yaz and other widely-used birth control pills should be updated to emphasize recent data suggesting a higher risk of blood clots with the drugs than older contraceptive pills.
READ MORE::

Bayer Charged With Burying Negative VTE Data for Yasmin
- Medpage Today
12/07/2011 - A former FDA commissioner accused Bayer of hiding data on the blood clot risks associated with two of its birth control pills, Yasmin and Yaz, and engaging in "extensive" off-label promotion in order to increase sales.
READ MORE::

FDA eyes stronger warning on popular birth control
- Reuters
12/07/2011 - U.S. Food and Drug Administration staff reviewed studies comparing an older generation of birth control with newer pills that contain the compound drospirenone, such as Bayer AG's popular Yaz and Yasmin.
READ MORE::

Should the FDA Recall Yaz and Yasmin?
- Ennis & Ennis
12/06/2011 - The Food and Drug Administration’s (FDA) primary responsibility is to ensure that all medications it evaluates and approves are safe for public use. The pharmaceutical companies presumably extensively research and test new medications and provide this data to the FDA’s Center for Drug Evaluation Research (CDER). Unfortunately, the CDER conducts no research or testing, rather it simply relies on the data provided to it by the drug company. Ennis & Ennis, P.A. questions this process.
READ MORE::

Bayer Withheld Yasmin Data From U.S., Former Agency Chief Says
- Bloomberg
12/06/2011 - A Bayer AG unit withheld from U.S. regulators findings by company researchers of increased reports of blood clots in users of its Yasmin birth-control pills, the former head of the Food and Drug Administration said.
READ MORE::

Safety Of Newer Birth Control Drugs Under Review By FDA
- Huffington Post
12/05/2011 - Birth control drugs that were heavily promoted as having fewer side effects and the ability to clear up acne and other hormonal bothers are under new scrutiny from safety regulators. Research suggesting that newer birth control formulations are more likely to cause blood clots than older drugs has prompted the Food and Drug Administration to consider new safety measures in meetings later this week.
READ MORE::

Smoking Gun Email Reveals Bayer Promoted Yaz For Uses Not Approved By FDA Explains Ennis & Ennis PA
- Ennis & Ennis
12/01/2011 - Bayer unit officials may have intentionally sought to market Yaz birth control pills for unapproved uses and mislead consumers about the potential health risks associated with the drug, as evidenced in company emails, reported Bloomberg. "Considering that our clients had other birth control options available to them, yet detrimentally relied upon Yaz and all that it claimed to treat, when they actually had safer alternatives available to them, this would be a complete travesty," commented Attorney Holly Ennis of Ennis & Ennis, P.A.
READ MORE::

Young woman’s death leads to questions about popular contraceptive known as YAZ
- VTDigger
12/01/2011 - On late Saturday afternoon, Nov. 12, when April Bapp of Brownington got a phone message from her daughter Rebecca, who didn’t feel well and was having trouble breathing. She was working that day at Community College of Vermont in Newport, and there was no one else in the building. She didn’t think she could get herself to a doctor, so her parents drove to Newport and brought her to North Country Hospital.
READ MORE::

Safety of birth-control pills under review
- The Columbus Dispatch
11/27/2011 - Concerns about an elevated risk of blood clots linked to certain birth-control pills will be discussed early next month by a Food and Drug Administration committee, which could recommend stronger warnings about potentially life-threatening problems.
READ MORE::

Yasmin birth control lawsuit a 1st in Canada
- CBC
11/27/2011 - The relatives of a woman who died in Toronto after taking Yasmin birth control pills have launched the first individual civil lawsuit against the drug manufacturer in Canada. Vicky Caprice Mersereau, 26, died in 2009 of a large pulmonary embolism after she ingested Yasmin, the legal firm representing Mersereau said in a statement to CBC News.
READ MORE::

Bayer emails mention of off-label uses for Yaz, Yasmin
- FiercePharma
11/22/2011 - Note to pharma marketing pros: Avoid using the word "off-label" in your emails. As Bloomberg reports, some messages discussing potential off-label promotions for the birth control pills Yaz and Yasmin have found their way into a lawsuit over their safety. Some 10,000 suits allege Bayer downplayed risks of the drugs--which recently have been linked to a 74% increase in blood clots--while promoting them aggressively.
READ MORE::

Bayer May Have Pitched Birth-Control Pill for Unapproved Use
- Bloomberg
11/21/2011 - Units of Bayer AG (BAYN), Germany’s largest drugmaker, may have sought to market the Yasmin family of birth- control pills for unapproved uses and misled women about the health risks the drug posed, according to company e-mails.
READ MORE::

Judge Denies Request to Use Confidential Yaz Documents to Petition to FDA
Explains Ennis & Ennis, PA
Ennis & Ennis, P.A. Explains the Ruling that Certain Documents Involved in the Yaz Litigation Are Deemed Protected and Confidential
- Ennis & Ennis
11/16/2011 - Last week Chief Judge David R. Herndon denied Plaintiff’s request to use certain “protected” documents from the Yaz litigation to petition the FDA and its advisory committee concerning public health issues associated with drospirenone-containing birth control pills, such as Yaz. Attorney David Ennis of Ennis & Ennis, P.A. commented on the ruling stating, “It’s a shame that certain documents are kept confidential, especially when they may include critical information for the FDA’s determination of the safety of Yaz; however it is understandable that the certain information is protected in order to preserve the discovery process.”
READ MORE::

Drospirenone-containing pill linked with raised thrombosis risk
- Pulse
11/11/2011 - Drospirenone-containing contraceptives pills, such as Yasmin, are associated with a significantly higher risk of deep vein thrombosis and pulmonary embolism than older-generation medicines, new research finds.
READ MORE::

Yet Another Study Confirms Yaz Increases Risk of Blood Clots
Ennis & Ennis, P.A. explains the findings of another recent study revealing the significant risk of developing dangerous blood blots associated with birth control pills such as Yaz and Yasmin.
- Ennis & Ennis
11/09/2011 - The Canadian Medical Association Journal released a study of 330,000 Israeli women indicating that blood clots were more likely for those who were taking Yaz and Yasmin, which are birth control pills that contain the synthetic hormone drospirenone, reported attorney David Ennis.
READ MORE::

Newer birth control pills again tied to blood clots
- Reuters
11/08/2011 - A study out Monday adds to evidence that a newer type of birth control pill may carry a higher risk of blood clots than older versions. The study, of 330,000 Israeli women, found that those who used birth control pills with the hormone drospirenone -- found in brand-names like Yaz and Yasmin -- were more likely than other Pill users to develop blood clots called venous thromboembolisms.
READ MORE::

FDA: Newer contraceptives linked to VTE
- Cardiovascular Business
11/01/2011 - In a retrospective cohort study of women using contraceptives, the FDA reported that the norelgestromin/ethinyl estradiol (NGMN) transdermal patch (Ortho Evra), drospirenone/ethinyl estradiol pill (DRSP; Yaz) and the etonogestrel/estradiol vaginal ring (ETON; NuvaRing) put women at a higher risk for venous thromboembolism (VTEs) when compared with standard low-dose contraceptives.
READ MORE::

FDA Cites Increased Blood Clot Risk to Yaz and Yasmin
10/31/2011 - A new study released by the Food and Drug Administration (FDA) on October 27, 2011 revealed that the popular birth control pills, Yaz and Yasmin, certainly increase blood clots risks by almost 74%, reported Attorney David Ennis.
READ MORE::

Study Confirms Higher Blood Clot Risk with Newer Birth Control Pills
10/31/2011 - A study published on October 25, 2011 by The British Medical Journal confirms previous findings that certain oral contraceptives containing newer types of progestogen hormones (drospirenone, desogestrel or gestodene), which are found in Yaz or Yasmin, at least double the risk of developing venous thromboembolism (VTE), compared to oral contraceptives with an older progestogen hormone (levonorgestrel), explains Attorney David Ennis.
READ MORE::

Combined Hormonal Contraceptives (CHCs) Study Shows Risk of Cardiovascular Disease.
- FDA
10/27/2011 - The FDA has released a PDF showing the results of a recent study of oral contraceptives such as Yaz, Yasmin and Ocella and found that those that contained the hormone drospirenone carried an increased risk of blood clots and other cardiovascular events when compared to other contraceptives that did not contain drospirenone.
READ MORE::

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
- BMJ
10/27/2011 - A Recent study of oral contaceptives shows that those containing drospirenone carry twice the risk of venous thromboembloism. The information below shows the results of this study.
READ MORE::

More Blood Clots Seen With Newer Birth Control Pills
- MedPage
10/26/2011 - Newer forms of progesterone in combination hormonal contraceptives carry higher venous thromboembolic (VTE) risk than older forms, a population-based study affirmed.
READ MORE::

Study: Yaz Has Higher Risks of Blood Clots
- New York Times
10/26/2011 - A new study of 1.3 million Danish women over nine years adds to the evidence that some newer birth-control pills, including the best-seller Yaz, have a higher risk of causing potentially dangerous blood clots.
READ MORE::

New Studies Find Yaz More Risky Than Other Leading Birth Control Pills: ABC News Investigates
- ABC News
10/26/2011 - The blockbuster birth control pill with benefits, Yaz was pitched as the choice for women desperate for relief from severe PMS and acne. But now, new independent studies have found that Yaz carries higher blood clotting risks than other leading birth control pills.
READ MORE::

Study: Newer Birth Control Pills May Double Blood Clot Risk
- WebMD
10/26/2011 - Women who take newer birth control pills appear to get dangerous blood clots in their veins about twice as often as women on an older pill formulation. That was the finding of one of the largest studies ever to look at the link between blood clots and hormonal contraception.
READ MORE::

FDA concerned about certain birth-control pills
- Nurse.com
09/29/2011 - The Food and Drug Administration has informed the public that it remains concerned, although it has not yet reached a conclusion, about the potentially higher risk of blood clots with the use of drospirenone-containing birth control pills.
READ MORE::

FDA Issues Safety Communication on Birth Control Pills Yaz, Yasmin and Other Drospirenone Pills
- Ennis & Ennis
09/28/2011 - On September 26, 2011, the U.S. Food and Drug Administration (FDA) released a Safety Communication reporting that it “remained concerned” about the potential increased risk of blood clots associated with the use of drospirenone-containing birth control pills. http://www.fda.gov/Drugs/DrugSafety/ucm273021.htm Drospirenone is the synthetic progestin ingredient used in certain birth control pills such as Yaz, Yasmin, Safyal, Beyaz and Zarah (name brands) and Ocella (generic).
READ MORE::

FDA Still Reviewing Clot Risk for Birth Control Pill
- MedPageToday
09/27/2011 - Four months after announcing that it was reviewing the safety of certain drospirenone-containing oral contraceptives, following reports of heightened risk for blood clots, the FDA said Monday that it still had not reached a conclusion.
READ MORE::

Newer Contraceptive Pills Could Raise Clot Risk, FDA Warns
- HealthDay News
09/27/2011 - U.S. health officials issued a cautionary note Monday about an increased risk of blood clots in women taking newer forms of birth control pills, such as Yaz or Yasmin. Although stopping short of a definitive statement, the U.S. Food and Drug Administration (FDA) did say it "remains concerned" about a potentially higher risk of blood clots in women taking the "fourth generation" pills containing drospirenone, a new type of synthetic progestin.
READ MORE::

FDA Flags Concern on Birth-Control Pill
- WSJ
09/27/2011 - The U.S. Food and Drug Administration said Monday it "remains concerned" a certain type of birth-control pill that contains drospirenone could raise the risk of blood clots beyond that of other pills.
READ MORE::

Bayer targeted by 53 plaintiffs in St. Clair County 'Yaz' suit
- St. Clair County Record
09/22/2011 - An additional 53 people from across the country have filed a lawsuit against the manufacturers of the birth control pill Yasmin and Yaz in St. Clair County Circuit Court. Lead plaintiff Wendy Ridge and 52 others are suing Bayer, alleging their ingestion of the birth control pill caused them to experience gallstones and a blood clot. The suit was filed Aug. 8. The lawsuit is one of many filed in St. Clair County since 2009 against the makers of the birth control pill.
READ MORE::

Pharmacists named in Yaz wrongful death suit
- Madison County Record
08/23/2011 - The mother of a recently deceased girl has filed suit against the manufacturer of a birth control pill, alleging her daughter died after developing a blood clot formed while taking the pill. Dana A. Martin claims her daughter, Sophia Claire Martin, was taking the birth control pill Yaz at the time of her death on July 10, 2009.
READ MORE::

Herndon orders Yasmin case to be reinstated
- Madison Record
08/15/2011 - A U.S. District Court judge has ordered that a suit filed against Bayer by the mother of a deceased woman be reinstated. The mother claims her daughter died after taking the birth control pill, Yasmin. Paulette Morgan as survivor for Alice Morgan filed a lawsuit in 2009 in U.S. District Court for the Southern District of Illinois after she claims her daughter suffered blood clots that led to her death. At the time of Alice Morgan's death, she was taking the birth control pill, Yaz.
READ MORE::

Madison County woman sues Yasmin makers, distributors over gallbladder issues
- Madison County Record
07/27/2011 - A Madison County woman claims her gallbladder was permanently damaged by birth control pills. Charese Shadwick filed a lawsuit July 11 in Madison County Circuit Court against Bayer A.G. Bayer Corporation, Bayer Healthcare LLC, Bayer Pharmaceuticals Coporation. Bayer Healthcare Pharmaceuticals, Berlex Laboratories Inc., Berlex Inc. and Walgreens Company are also named as defedants.
READ MORE::

Lawsuits mounting over alleged health risks of Bayer's Yaz contraceptive
- The Star-Ledger
07/11/2011 - Michelle Pfleger, a teenager from Hackettstown, was familiar enough with the birth control pill Yaz to ask for it when she visited her doctor before heading off to college. She had seen the advertisements on television about how the drug could help clear up mild acne, relieve premenstrual irritability and, if she needed it, could prevent her from getting pregnant. But in May, Cummins filed a lawsuit against Bayer Healthcare, the drug company that sells Yaz, alleging that the birth control pill caused her 18-year-old daughter’s death nearly a year ago.
READ MORE::

FDA Assessing Increased VTE Risk Associated with Yasmin, Yaz, and Ocella Birth Control Pills
- Nutrition.Diet News
07/05/2011 - Recent studies have been carried out on the birth control treatment known by the brands Yasmin or Yaz, results were released in the British Log of Medicine in Apr 2011. Both studies looked at groups of women in between 15 and 46 who were taking birth control pills containing drospirenone as well as levonorgestrel. According to the studies, users of the birth control medications made up of drospirenone (such as Yasmin or Yaz) provide an increased risk with regard to developing blood clots, called venous thromboembolism (VTE).
READ MORE::

Taking the Pill for Acne Was Fatal, Dad Says
- Courthouse News Service
06/20/2011 - A father says his 15-year-old daughter, who was not sexually active, died of pulmonary embolisms from taking Yasmin and Ocella, contraceptives that a doctor prescribed for acne. The father claims Bayer "aggressively" promoted the contraceptives for off-label uses, and "ignored" the "serious risks associated with the drug."
READ MORE::

US reviewing pill after blood clot risk study
- SA Time
06/14/2011 - The US Food and Drug Administration said it is reviewing recently published studies which have pointed to an increased blood clot risk associated with a certain type of birth control pill. The studies involve pills that contain drospirenone, as opposed to another type of progestin known as levonorgestrel. Some brand names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.
READ MORE::

FDA Safety Alert: Birth Control Pills Containing Drospirenone May Cause Higher Risk of Blood Clots
- empowher
06/08/2011 - The U.S. Food and Drug Administration (FDA) recently released a safety alert for women taking birth control pills with drospirenone. The reason: a possible risk of increased blood clots. Most birth control pills contain two types of hormones, estrogen and progestin. The FDA described drospirenone as a type of female sex hormone called a progestin.
READ MORE::

Health Canada reviewing safety of Yaz, Yasmin pills
- CTV.ca
06/07/2011 - Health Canada is reviewing the safety of Bayer's birth control pills Yaz and Yasmin over concerns that they might raise women's risk of blood clots more than other birth control pills. Although all hormonal birth control pills raise the risk of clots, Health Canada's review focuses on Yaz and Yasmin because both contain drospirenone. Drospirenone is a synthetic progesterone called progestin; other pills contain other types of progestin.
READ MORE::

Why Making A Safer Birth Control Pill Is So Hard
Yasmin birth control pills are among those that contain drospirenone, a synthetic hormone that appears to carry an elevated risk for blood clots
- Shots
06/06/2011 - It's a quest that never seems to end — the search for a safer birth control pill. Some thought it might be at hand almost a decade ago when a new generation of oral contraceptives came on the market. They contained a hormone called drospirenone, which some thought would be less likely to cause dangerous blood clots.
READ MORE::

Newer Birth Control Pills Carry a Higher Risk of Blood Clots
- TIME
04/25/2011 - Two studies published in the British Medical Journal confirm that birth control pills increase the risk of blood clots.
READ MORE::

Bayer’s Deadly Birth-Control Pills: Alleged Toll Climbs to 190, Shareholders Revolt
- BNET.com
04/15/2011 - About 190 women have died while taking Yaz and Yasmin, Bayer’s (BAYRY) two leading contraceptive pill brands, according to the Swiss media, and the company faces a shareholder motion condemning its marketing of the brands at its April 29 annual meeting.
READ MORE::

Yaz, Yasmin Birth Control Pills
- Philadelphia Inquier
11/23/2010 - The popular birth control pills Yaz and Yasmin have attracted a swarm of negative attention the last two years. The most worrisome allegation against them is that they cause increased risks of dangerous Yaz blood clots.
READ MORE::

Do Birth Control Pills Cause Gallbladder Damage? Bayer Will Find Out In Court
-BNet.com
10/26/2010 - Bayer faces 4,200 lawsuits on its Yaz contraceptive franchise, more than double the number previously thought, an indicator of how fast the potential liabilities are piling up around the company’s tentpole revenue driver. If a handful of “bellwether” trials go the wrong way for Bayer, that liability could spread to Teva (TEVA), which recently started making a generic version of Yaz and its sister birth control pills.
READ MORE::

Yaz Side Effects
-Hellium.com
09/21/2010 - Yaz is a brand name version of the combined drospirenone and ethinyl estradiol medication. Yaz is an oral contraceptive that uses hormones to prevent eggs from becoming fertile. It is also used to treat severe premenstrual syndrome, a condition called premenstrual dysphoric disorder or PMDD. The side effects of Yaz can be wide-ranging and while they are usually minor, they can become far more serious in people who smoke.
READ MORE::

Yaz Sales Reps Must Produce Files For National Litigation
-NPR
08/23/2010 - Bayer HealthCare, the leading maker of birth control pills, is coming out with a brand new pill. Natazia, as it's called, contains a form of estrogen that's never been used in an oral contraceptive. It also has a novel dosing regimen. Women on Natazia will take four different combinations and doses of hormones or sugar pills each month.
READ MORE::

Yaz Sales Reps Must Produce Files For National Litigation
-WBZTV.com
05/07/2010 - Sales representatives who handled hormone replacements Yasmin, Yaz, Ocella, and Gianvi must produce all their files for national litigation.
READ MORE::

Are Women Safe On Birth Control Pill Yaz?
-WBZTV.com
05/07/2010 - Millions of women take birth control pills every day, and all of these medications carry a small amount of risk of serious health complications. Some women believe the most widely prescribed pill on the market is more dangerous than the rest.
READ MORE::

Birth control pills Yaz and Yasmin concerns bring lawsuits but few solid answers
-LA Times
04/19/2010 - Yaz and Yasmin complaints focus on the synthetic progestin, drospirenone. Studies have not found an increased risk with these pills, though. When the oral contraceptives Yasmin and Yaz came on the market in 2001 and 2006, respectively, they were thought to be safer than other birth control pills because they contained a different kind of synthetic progestin. But in a flurry of lawsuits against the pills' maker, Bayer HealthCare, attorneys claim that the progestin contained in the pills, drospirenone, is the cause of health problems, including deep vein thrombosis (blood clots in the deep veins), strokes, heart attacks and gallbladder disease.
READ MORE::

Yaz revises ad campaign amidst lawsuits
-WISH
04/14/2010 - In the wake of mounting lawsuits, Bayer Pharmaceuticals is issuing new warnings regarding its contraceptives called Yaz and Yasmin. The two birth control pills make big bucks for Bayer. The pharmaceutical giant racked up $1.3 billion from the drugs in the first three quarters of 2009 alone.
READ MORE::

Bayer HealthCare to Put Safety Labels on Birth Control Pills
-Top News
04/12/2010 - Bayer HealthCare announced on Friday its recent move of labeling its contraceptive pills Yaz and Yasmin with added information on the risks of blood clots, aiming to avoid controversies and raise transparency. The company has taken the step forward in the direction under the recommendations of the Food and Drug Administration, following the trend like other oral contraceptives.
READ MORE::

Calgarians join class action $15M lawsuit against Yaz and Yasmin birth control
- Calgary Herald
04/12/2010 - Eight months after Chloe Papparis began taking a birth control pill for acne, she almost died from severe side-effects, she says. The teen started suffering from a bad migraine headache and frequent bouts of vomiting last August. Her family doctor thought it might be swine flu. Six days later, however, Papparis was rushed to Foothills Hospital. Doctors told her she was 24 hours from dying. "When I was in ER, the doctor by fluke said to give me a CT scan. They found five blood clots on my brain," Papparis, now 18, said Thursday.
READ MORE::

Woman files lawsuit against Bayer for Yasmin health affects.
-Justice News Flash
03/23/2010 - Bayer Pharmaceuticals is facing a lawsuit that contends the drug maker knowingly sold birth control pills that were risky, which led to the plaintiff’s organ failure as a result of taking the pregnancy-preventative drug. The lawsuit was filed in the San Mateo Superior Court, by the plaintiff, Louise Thanos, of Montara, as reported by the San Jose Mercury News.
READ MORE::

About 1,100 Birth Control Lawsuits Over Yaz, Yasmin and Ocella Filed
-Oromo Index
03/19/2010 - The number of birth control lawsuits over Yaz, Yasmin and Ocella filed against Bayer Health Care has risen to about 1,100 cases, according to an annual report released by the drug maker, and the number will likely continue rising rapidly over the next year as thousands of other women are considering claims for serious injuries that may have been caused by side effects of the birth control pills.
READ MORE::

Montara woman sues drug company over birth control pills
-Mercury News
03/18/2010 - A Montara woman has filed a lawsuit against Bayer Pharmaceuticals asserting it sold birth control pills that it knew were risky and that she suffered organ failure as a result of taking them. Louise Thanos took Yasmin birth control pills, which are also called Yaz, from November 2007 to November 2009, but in March 2008 she had major health problems, including gallbladder failure, the lawsuit filed in San Mateo County Superior Court says.
READ MORE::

Lawsuit against Yasmin/Yaz birth control pill filed by Canadian women
-Top News NZ
03/15/2010 - Bayer's popular oral contraceptives Yaz and Yasmin have a number of lawsuits being filed against them by a group of Canadian women. These women have alleged that the warnings on the pills were not adequate as there were cases of stroke and other health problems being faced by women.
READ MORE::

Bayer Accused in Canadian Lawsuit of Hiding Yaz Risks
-Bloomberg
03/11/2010 - Bayer AG, Germany’s largest drugmaker, was accused in a lawsuit of ignoring health risks of the contraceptive Yaz and advertising the drug as safe to boost sales. The Yasmin family of birth-control pills, known as Yaz and Yasmin, carries a four times increased risk of deep vein thrombosis and pulmonary embolism compared with other contraceptives, according to the suit, filed today in St. Catharines, Ontario, by two women. They seek class-action, or group, status to represent all women who used the drugs.
READ MORE::

Yaz, Yasmin, and Ocella Birth Control Controversy Surround Bayer
-24/7 Press
03/05/2010 - Controversy continues to surround Yaz and Yasmin, the most popular contraceptive pills in the country and the top-selling pharmaceuticals for Bayer HealthCare. The Food and Drug Administration recently determined advertising campaigns for the pills to be dangerously misleading because they overstate the drug's ability to improve acne and other conditions while understating the dangers posed by potential side effects. Quality control issues at a manufacturing plant that produces some of the hormones in the pills also drew the fire of the FDA, which provided Bayer with a warning letter regarding the problems.
READ MORE::

Bayer's Birth-Control Problem Is Exploding: 1,100 Lawsuits Allege Yaz Causes Blood Clots
-BNET
03/01/2010 - About 1,100 lawsuits have been filed against Bayer (BAY.DE) alleging its top-selling Yaz birth control pill causes potentially fatal blood clots, the company disclosed in its 2009 annual report. While it was well-known that the brand was attracting litigation — at least 129 suits were reported filed against it in November 2009 — the disclosure indicates that Bayer’s Yaz problem is far larger than previously anticipated.
READ MORE::

Woman Says "Yaz" Caused Blood Clots
-WREG News
03/01/2010 - Vicki Parsons had a near death experience three years ago. In June of 2007, she and her husband were on vacation when she noticed a pain in her foot. Days later she was rushed to the hospital. The doctor came back with bad news. "The doctor came in there and scratched his head and I was like what's wrong. He said you have a massive blood clot in your lungs and in your leg," said Parsons. Puzzled, the doctors ran different tests. In the end, they said it was her birth control. Parsons says she started taking Yaz just three weeks before.
READ MORE::

Did Popular Birth Control Drug Cause Death?
-WREG
02/18/2010 - There are a growing number of lawsuits across the country from women claiming to have been harmed by the birth control drug, Yaz. The latest involves the death of a local college student who had been taking YAZ for six months.
READ MORE::

Indy woman speaks on birth control suit
-WISHTV
02/11/2010 -Yaz and Yasmin Lawsuits have been filed in Indianapolis against Bayer Pharmaceuticals. Women across the country claim that the birth control pills Yaz and Yasmin caused serious health effects. One of those women is Gina Miller, the chief financial officer at a downtown Indianapolis company. She's a wife and mother of three young children, and as if all that weren't enough to keep her busy, she also runs up to 35 miles a week. To maintain this schedule, you have to be pretty healthy, and Miller was until she began taking Yaz, a contraceptive.
READ MORE::

Top-selling contraceptive Yaz stirs controversy
-The Daily Aztec
02/11/2010 - Many women have relied on contraceptives to prevent unplanned pregnancy for more than half a century. And in 2006, one pill claimed to be “beyond birth control,” promising to treat acne and premenstrual syndrome, thus enticing more women to choose this pill instead of others on the market. But a recently filed lawsuits and a $20 million corrective ad campaign for misleading commercials have raised questions about the safety of this pill.
READ MORE::

Hoosier women sue Bayer over Yasmin pill
Birth control pills did serious damage, they say; maker calls products safe
-Indy Star
02/08/2010 - More than 50 women claim in lawsuits filed in Indianapolis that they suffered strokes, heart attacks or other serious health problems while taking the birth control pills Yasmin or Yaz, manufactured by Bayer Healthcare Corp. Across the nation, dozens of lawsuits have been filed in the past few months by women claiming similar health problems after taking the pills.
READ MORE::

Yaz Gallbladder Removal Lawsuit Filed Against Bayer By Woman
-Ennislaw
01/29/2010 - A Michigan woman has filed a lawsuit against Bayer over its popular birth control pill Yaz, alleging that side effects caused her to have her gallbladder removed and suffer blood clots. The Yaz lawsuit was filed yesterday in the U.S. District Court for the Eastern District of Michigan by Asia Moore. It is among hundreds of other cases pending against the makers of Yaz that involve allegations that the drug maker failed to adequately research the potential side effects of Yaz or warn about the increased risk of gallbladder disease, stroke, heart attack, pulmonary embolism, deep vein thrombosis or sudden death.
READ MORE::

Woman Files Lawsuit Against Yaz Manufacturer Following Stroke
-DrugWatch
01/20/2010 - A woman filed a lawsuit against Bayer HealthCare, the manufacturer of Yaz birth control, after she experienced a stroke and other serious side effects while taking Ocella, a generic version of the oral contraceptive.
READ MORE::

Yaz, Yasmin Birth Control Pills Side Effects Prompt New Round of Lawsuits
-DFW Catholic
01/18/2009 - Jesse, the mother of a newborn in Bloomfield, NE, began taking the birth control pill Yasmin and never suspected it would cause problems. She had talked to her doctor about its possible side effects and he mentioned only blood clots. But after only a few months on the drug, she suffered severe stomach pains, and a medical exam revealed that she needed gall bladder surgery.
READ MORE::

Yaz Contraceptive lawsuits going to trial
-UPI
01/12/2010 - The federal courthouse in East St. Louis, Ill., will hold pretrial proceedings for as many as 25,000 lawsuits involving a popular contraceptive, officials say. The lawsuits against Bayer Corp., makers of the contraceptive pill Yaz, have been filed all over the country, but will be handled by U.S. District Chief Judge David Herndon as a multidistrict litigation assignment, the Belleville News-Democrat reported Monday.
READ MORE::

Another Woman Dies of Hormonal Contraceptive in Switzerland from Pulmonary Embolism
-LifeSiteNews
12/26/2009 - The Swiss Federation of Service to Patients (Patientenstellen der Schweiz) has called for a ban on a particular type of contraceptive pill after it was linked to the death last month of a 17-year-old German girl who died in a Swiss hospital. The girl, who died at the University Hospital of Basel, was taking a pill that includes drospirenone, a synthetic progestin, which is a compound included in newer brands, such as Yaz, Yasmin, and Yasminelle.
READ MORE::

YAZ, Yasmin lawsuits filed locally against Bayer
-TribLive
12/17/2009 - Bayer Corp. was named in at least a half-dozen federal lawsuits filed this week in Pittsburgh alleging the company's birth control products called YAZ and Yasmin are unsafe and potentially deadly.
READ MORE::

Yaz, Yasmin, and Ocella Birth Control Serious Side Effects Risks
-J.Murawski
12/14/2009 - Many women across the nation have sustained serious injury after taking contraceptives under the names Yaz, Yasmin, or Ocella. Users of these drugs have reported serious side effects such as strokes, heart attacks, DVT (blood clots in legs), Pulmonary Embolism (blood clots in lungs, and dehydration, leading to kidney stones or gall bladder disease.
READ MORE::

Yaz, Yasmin, and Ocella Birth Control Lawsuits
-TheDailyNews
12/10/2009 - The latest “problem drug” TV commercials about Yaz, Yasmin and Ocella – which are known to cause blood clots, strokes and even death in some women – have been tough to miss. The birth control pills are manufactured by Bayer Healthcare and Barr Laboratories. Meanwhile, attorneys have seen “several dozen cases and we get more every day,” said one lawyer of a mass tort litigation group, which is primarily responsible for handling the multitude of cases.
READ MORE::

Bayer sued over birth control Yaz's risks
-The Washington Times
12/01/2009 - After 13 hours of intensifying pain, two trips to the emergency room and two CT scans, doctors finally found what was ailing Lottie Green. In her left lung, the pulmonologist told her, was the largest blood clot they had ever seen and there were others in her right lung as well, she said. Soon after the 41-year-old Bethesda, Md., resident was released from a hospital last month, Ms. Green joined hundreds of other women in lawsuits against Germany's Bayer AG, the maker of the popular oral contraceptive Yaz.
READ MORE::

New Yasmin/Yaz Medical Research
-Drug Recall Lawyer Blog
12/01/2009 - A flurry of new medical articles have come out in the past week regarding Yasmin and Yaz. Here are links and some “talking points.”
READ MORE::

Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills
-PRWeb
11/24/2009 - Ennis & Ennis, P.A. is offering free nationwide confidential consultations for users of Yaz and Yasmin birth control pills who have suffered a Deep Vein Thrombosis (DVT), Pulmonary Embolism, Stroke, Heart Attack or other related cardiac issues or had their Gallbladder removed. Women can call toll free at 1-800-856-6405 or go to the firm’s website at http://www.ennislaw.com and fill out an online case evaluation form. Ennis & Ennis also recommends women who have had these Yaz side effects to go to www.fda.gov and fill out a Medwatch form so the FDA becomes aware of the seriousness of this issue. Attorney Holly Ennis does not recommend discontinuing use of Yaz or Yasmin unless first consulting with your physician.
READ MORE::

Pittsburgh Mother Joins Lawsuit Against Yaz Birth Control Pill
Mom Says Daughter Was Taking Yaz When She Fell Ill
-ABC News
11/24/2009 - A Pittsburgh-based drug company has been hit with a lawsuit claiming it misled women, including a local teenager whose mother says her daughter nearly died from birth control. "She was short of breath, she was having severe chest pains and her face was changing colors," said Dana Kraus of her daughter. Kraus said her 15-year-old daughter, Katie, had been taking the conceptive Yaz for about six months when the teen suddenly felt like she was suffocating.
READ MORE::

Yaz pilots Google sponsored links format
-Medical Marketing & Media
11/19/2009 - Bayer's Yaz is trying out a paid search format similar to that proposed by Google for products carrying black-box warnings. The Yaz-branded sponsored link appears in a yellow-highlighted box atop Google searches on terms including “Yaz,” “the pill” and “birth control.”
READ MORE::

Bayer Tries New Google Drug Ad Format But Lawyers Spoil the Party
-BNET
11/18/2009 - Bayer is trying out the new Google-invented ad format that includes a fixed link to a drug’s risk and side effect information. The ads are for Yaz, Bayer’s troubled contraceptive. The experiment will be closely watched by other drug companies, all of whom are seeking a way to utilize Google ads without falling afoul of the FDA, which previously warned against their use because the tiny, text-based promos do not contain warning information.
READ MORE::

Yaz Side Effects: FDA Warning Letters
-InjuryBoard
11/17/2009 - The Food and Drug Administration (FDA) has sent several warning letters to Bayer HealthCare Pharmaceuticals, Inc. for what the FDA termed “misleading” advertising spots it found “particularly troubling” because they served to “undermine the communication of important risk information, minimizing these risks and misleadingly suggesting that Yaz is safer than has been demonstrated by substantial evidence or substantial clinical experience.”
READ MORE::

US judge requests mass tort status for Yasmin birth control pill claims
-Michelmores Medical Negligence News
11/13/2009 - With the growing numbers of claims in the US alleging an increased risk of pulmonary embolism and other severe side-effects from the oral contraceptive Yasmin, a court in New Jersey has requested that the actions be centralised and given mass tort status.
READ MORE::

Birth control dangers
-Fox News
11/12/2009 - Within the past year both Christine Navarro and Robyn Dunn were rushed to the hospital with life threatening blood clots. At the time Christine was taking the Yaz birth control pill and Robyn was taking its sister birth control drug Yasmin.
READ MORE::

Birth control pill makers targeted in Madison County
- Madison County Record
11/11/2009 - After a birth control pill spent months in the spotlight during commercials aimed at correcting misrepresentations about it, the pill is now at the center of a Madison County lawsuit. Cathy M. Walton filed a lawsuit Nov. 4 against Bayer and its subsidiaries, Berlex and its subsidiaries and an unknown number of manufacturers, alleging her ingestion of the birth control pill Yasmin, which is similar to Yaz, forced her to undergo surgery to remove her gall bladder.
READ MORE::

Birth Control: Bitter Pill
-KTLA News
11/11/2009 - LOS ANGELES -- "I woke up and I couldn't breathe. The pain was unimaginable. I can't even describe it." Christine Navarro, 22, is recalling the worst night of her life. "It felt like someone was squishing my lung, and pushing on the entire left side of my body." And Robyn Dunn, a 31 year-old ultra-marathoner, has a similar memory. "I was having a lot of anxiety, out of breath, and I knew something was wrong, and that I should stop that race. And I've never dropped out of any race in my entire life." Within the past year both Robyn and Christine were rushed to the hospital with life-threatening blood clots. At the time, Christine was taking the 'Yaz' birth control pill.
READ MORE::

Suicide Blamed on Acne Drugs
-Courthouse News
11/01/2009 - Parents say their daughter committed suicide because drug companies failed to warn them of the side effects of their acne drugs. Their daughter, whose age is not specified, killed herself after taking Claravis and YAZ for acne, the parents claim in Mahoning County Court.
READ MORE::

Newark woman sues maker of Yaz birth control
- Oakland Tribune
10/23/2009 - A 39-year-old Newark woman has filed a lawsuit this week against Bayer Corp., blaming its popular birth control product Yaz for causing her stroke and other related health issues. Susan Galinis, the mother of 3-year-old twin girls, took the prescription-only product for four weeks in the summer of 2008, and wound up suffering a stroke that caused her to be hospitalized for six months, said her attorney.
READ MORE::

Lawsuits Against Yaz Increasing
-empowerher
10/22/2009 - While all birth control pills have side effects, Yaz and its sister pill, Yasmin (which contains less estrogen) seems to be taking the cake for increasing lawsuits for its effect on women.
READ MORE::

Pharmaceutical company behind Yaz forced to air corrective advertising
-Independent Florida Alligator
10/22/2009 - Back in 2008, pharmaceutical maker Bayer released a series of ads for Yaz, a birth control pill. The ads claimed that Yaz can treat various premenstrual symptoms and help clear up acne on skin. But oops-they weren't supposed to say that. The FDA said that these ads made claims that it hadn't approved, and they didn't adequately disclose the health risks associated with Yaz.
READ MORE::

Bayer under pressure as birth control pills linked to blood clots
-Deutsche Welle
10/21/2009 - A hormone in some birth control pills made by Bayer may cause dangerous blood clots, studies have found. The pills have been linked to several recent deaths, but a ban is considered unlikely.
READ MORE::

Bay Area woman sues Yaz birth control
-ABC News
10/20/2009 - A Bay Area woman says the popular birth control pill known as Yaz caused her to have a stroke which has devastated her life. She is suing the drug's maker, Bayer, to take the pill off the market.
READ MORE::

Bayer's Legal Woes: 125 Suits Over Yaz; FDA Allegedly Not Told of Trasylol Study
-BNET
10/19/2009 - Bayer faces more than 125 lawsuits over its Yaz contraceptive and new cases are being filed around the country at a rate of up to up to six a day, according to Courthouse News Service. The cases all claim the same thing: That the new progesterone ingredient that Bayer used for Yaz causes more dangerous blood clots to form than previous formulations.
READ MORE::

Pulmonary Embolism Leads To Woman's Death After Using Birth Control
-EmaxHealth
10/13/2009 - Swissmedic, the medical regulatory agency in Switzerland, is looking into the death of a young woman who suffered a pulmonary embolism that appears to be a side effect of her birth control medication. According to the agency, the woman had been using Yaz, an oral medication made by Bayer Pharmaceuticals, for about 10 months when her death occurred in mid-September.
READ MORE::

Deaths Linked To Trendy Birth Control Pill
-The Bulletin
10/12/2009 - It was mid-August, 2008, when 24-year-old Tanya Hayes began to experience breathlessness and what her family described as a “nasty, hard cough.” A busy student, Tanya ignored the symptoms until one afternoon when she collapsed in a car park in her hometown of Melbourne, Australia. Five hours later, she was pronounced dead of a pulmonary embolism.
READ MORE::

Woman alleges pill caused death of unborn baby, sues drug maker
-The Southeast Texas Record
09/30/2009 - A pregnant woman claiming her birth control pills are responsible for her blood clot and the death of her unborn baby has filed a wrongful death lawsuit against the drug's manufacturer.
READ MORE::

On Yaz, Bayer Believes "a Multiple of a Rare Event Is Still a Rare Event"
-BNET
09/29/2009 – The mainstream media has finally woken up to Bayer’s problems on its Yaz contraceptive brands. The New York Times published a story over the weekend about the 74 lawsuits against the company alleging that the pills cause potentially fatal embolisms in users. A close look at recent events at Bayer indicate that the company seems to see the world one way, even though everyone else sees it another.
READ MORE::

Yaz and Yasmin: the Facts Behind the Hype
-TheFasterTimes
09/29/2009 - The New York Times reported September 25 on the controversy surrounding Yaz and Yasmin, two popular birth control pills (BCPs). Part of the controversy stems from problematic marketing and manufacturing processes identified by the Food and Drug Administration. However, the principal concern is whether these medications increase the risk of blood clots.
READ MORE::

Are Yaz and Yasmine Safe? What You Should Know About Your Birth Control
-Twirlit
09/29/2009 - Conflicting reports are out about the safety of Bayer’s popular lines of birth control: Yaz and Yasmine. While a Bayer sponsored study shows the pills are no less safe than other birth control pills in their incidences of stroke or blood clots, some women, their attorneys and other researches argue just the opposite.
READ MORE::

Oral Contraceptive Linked to Death from Blood Clot
-MedIndia
09/28/2009 - German drugmaker Bayer is in serious trouble after Swiss medical authorities revealed that they are investigating reports that a woman died after consuming a low dose contraceptive manufactured by Bayer.
READ MORE::

Bayer’s Yaz Consumer’s Death Probed By Swiss Agency
-Bloomberg
09/26/2009 - Bayer AG, Germany’s largest drugmaker, said its Yaz contraceptive is part of an investigation by a Swiss health regulator into the death of a young woman who took the pill. The Swissmedic agency and an investigative judge are looking into the case of the woman, who died from the effects of pulmonary embolism, Bayer’s Swiss health unit said in a statement posted on its Web site yesterday.
READ MORE::

Health Concerns Over Popular Contraceptives
-The New York Times
09/26/2009 - The oral contraceptives Yaz and Yasmin are the top-selling pharmaceutical line for Bayer HealthCare, largely as a result of marketing that presents them as much more than mere pregnancy prevention. Yaz, in particular, the top-selling birth control pill in the United States, owes much of its popularity to multimillion-dollar ad campaigns that have promoted the drug as a quality-of-life treatment to combat acne and severe premenstrual depression.
READ MORE::

Pennsylvania Poised to be Center of State Court Yaz(R) Yasmin(R) Ocella(R) Birth Control Litigation
- US Newswire
09/17/2009 - Yesterday, Judge Sandra Mazer Moss, Philadelphia Court of Common Pleas, consolidated all lawsuits filed in Philadelphia that involve Bayer's popular birth control pills, commonly known as Yaz or Yasmin. Philadelphia is likely to be the country's center for state court litigation involving this widely used birth control pill.
READ MORE::

FDA Sends Warning Letter to Makers of Yaz – Yasmin
-US Recall News
09/17/2009 - As if the makers of Yasmin / Yaz didn’t have enough to worry about with pending lawsuits related to major side-effects, now they’ve been served a warning letter from the FDA for quality control problems at a plant in Germany that manufactures one of the ingredients in the drug.
READ MORE::

BMJ: Ingredient in Bayer's Yaz Causes More Blood Clots Than Rivals
-Bnet
09/12/2009 - Folks inside the Yaz brand management team at Bayer have another pill-induced headache this month in the form of a BMJ study that indicates the progesterone ingredient of Yaz is more risky than those in other contraceptives.
READ MORE::

Yaz/Yasmin birth control pills: Serial Killers?
-Examiner
09/08/2009 - Yasmin is the brand name for a birth control pill that is generically known as drospirenone. It is also a treatment for moderate acne and premenstrual dysphoric disorder (PMDD) in women. Yasmin is produced by Berlex Laboratories, Inc.(this name changed to Bayer Healthcare Pharmaceuticals in 2008) as an oral contraceptive.
READ MORE::

Yaz and Yasmin: Potentially Dangerous
-24-7 Press Release
09/05/2009 - Two recently released studies in the prestigious British Medical Journal show oral contraceptives including Yaz and Yasmin cause a dramatic increase in the risk of blood clots. The data indicates users of the pills are 6.3 times more likely to suffer blood clots that can lead to dangerous health problems such as heart arrhythmia, heart attacks and strokes.
READ MORE::

Yaz Lawsuits Heat Up – Is a Recall on the Horizon?
-US Recall News
09/02/2009 - Several lawsuits have been filed against Bayer due to serous side effects associated with Yasmin / Yaz. Here we discuss the implications such a lawsuit would have on a potential recall. Both the drugs are oral contraceptives that contain synthetic versions of the hormones estrogen and progestin, and are associated with side effects including stroke, heart attack, pulmonary embolism, deep vein thrombosis, gallbladder problems, and kidney problems.
READ MORE::

Birth control pill 'Yaz' named in suit against Bayer, Walgreens
-St.Clair Record
08/24/2009 - After a birth control pill spent months in the spotlight during commercials aimed at correcting misrepresentations about it, the pill is now at the center of a St. Clair County lawsuit. Kerry Sims filed a lawsuit Aug. 18 against Bayer and Walgreens, alleging her ingestion of the birth control pill Yasmin, which is also known as Yaz, caused her to experience a blood clot in her lung and infection surrounding the clot.
READ MORE::

Low-estrogen birth-control pills safer than others
European research finds that oral contraceptives with high doses of the hormone increase users' risk of blood clots
-The Globe And Mail
08/15/2009 - Many women are not using the safest birth-control pills possible, new research suggests. While it is well established that taking oral contraceptives slightly increases the risk of blood clots, two new European studies say that risk varies depending on the type of product chosen.
READ MORE::

THE most popular oral contraceptive in Ireland is not the safest, research suggests.
-IrishExaminer
08/14/2009 - Yasmin is the preferred choice among Irish women but it carries an almost six-fold added risk of blood clots, compared with women not on the pill.
READ MORE::

Serious Side Effects From Yaz and Yasmin Oral Contraceptives
-Best Syndication
07/15/2009 - If you are taking either Yaz or Yasmin birth control pills, be aware that there could be some severe effects on your health. Those who have elevated blood potassium should not take these pills, because they can raise your blood potassium. A high potassium level in the body can cause...
READ MORE::

If you or a loved one have suffered serious injury or death while using Yasmin, Yaz or the generic product Ocella, you may be entitled to compensation. Contact the birth control side effects lawyers of Ennis & Ennis, P.A. today for a free nationwide case evaluation. Our experienced attorneys can answer any questions you may have about Yaz, Yasmin, or Ocella side effects or a potential Yaz, Yasmin, Ocella lawsuit. Fill out the case evaluation form on this page or call toll free: 1-800-856-6405.

Under no circumstances should you discontinue taking any medication, including Accutane, without first consulting with your doctor.

Yaz Side Effects Lawsuit